Cargando…

Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider

OBJECTIVE: To update the EULAR 2020 systematic literature review (SLR) on efficacy and safety of immunomodulatory agents in SARS-CoV-2 infection. METHODS: As part of a EULAR taskforce, a systematic literature search update was conducted from 11 December 2020 to 14 July 2021. Two reviewers independen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alunno, Alessia, Najm, Aurélie, Mariette, Xavier, De Marco, Gabriele, Emmel, Jenny, Mason, Laura, McGonagle, Dennis G, Machado, Pedro M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infections
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562527/ https://www.ncbi.nlm.nih.gov/pubmed/34725262 http://dx.doi.org/10.1136/rmdopen-2021-001899

Ejemplares similares

Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider
por: Najm, Aurélie, et al.
Publicado: (2021)

Immunomodulatory therapies for SARS-CoV-2 infection: a systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2021)

EULAR points to consider on pathophysiology and use of immunomodulatory therapies in COVID-19
por: Alunno, Alessia, et al.
Publicado: (2021)

Assessment of competences in rheumatology training: results of a systematic literature review to inform EULAR points to consider
por: Alunno, Alessia, et al.
Publicado: (2020)

Characterisation of prodromal and very early psoriatic arthritis: a systematic literature review informing a EULAR taskforce
por: De Marco, Gabriele, et al.
Publicado: (2023)

EULAR points to consider for including the perspective of young patients with inflammatory arthritis into patient-reported outcomes measures
por: Studenic, Paul, et al.
Publicado: (2022)

SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry
por: Lawson-Tovey, Saskia, et al.
Publicado: (2022)

EULAR ‘points to consider’ for the conduction of workforce requirement studies in rheumatology
por: Dejaco, Christian, et al.
Publicado: (2018)

EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
por: Nagy, György, et al.
Publicado: (2022)

2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations
por: van der Heijde, Désirée, et al.
Publicado: (2015)

Impact of synovial biopsy procedures and disease-specific aspects on synovial tissue outcome: a systematic literature review informing the EULAR points to consider for the minimal reporting requirements in synovial tissue research in rheumatology
por: Najm, Aurélie, et al.
Publicado: (2022)

EULAR points to consider for the development, evaluation and implementation of mobile health applications aiding self-management in people living with rheumatic and musculoskeletal diseases
por: Najm, Aurélie, et al.
Publicado: (2019)

EULAR portfolio for Rheumatology training: a EULAR School of Rheumatology initiative
por: van Onna, Marloes, et al.
Publicado: (2021)

Methodological aspects of design, analysis and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis: results of two systematic literature reviews informing EULAR points to consider
por: Marques, Mary Lucy, et al.
Publicado: (2021)

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update
por: Gossec, Laure, et al.
Publicado: (2020)

EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis
por: Boonen, Annelies, et al.
Publicado: (2021)

EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors
por: Kostine, Marie, et al.
Publicado: (2021)

Mise à jour des recommandations EULAR sur l’utilisation des thérapies immunomodulatrices dans la prise en charge de la Covid-19
por: Najm, A., et al.
Publicado: (2021)

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis
por: Mankia, Kulveer, et al.
Publicado: (2021)

COVID – How will it continue to change our lives?
por: Najm, Aurélie, et al.
Publicado: (2023)

Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisations
por: Najm, Aurélie, et al.
Publicado: (2020)

Prevention and management of osteoporotic fractures by non-physician health professionals: a systematic literature review to inform EULAR points to consider
por: Wilson, Nicky, et al.
Publicado: (2020)

2019 EULAR points to consider for non-physician health professionals to prevent and manage fragility fractures in adults 50 years or older
por: Adams, Jo, et al.
Publicado: (2021)

Value of imaging to guide interventional procedures in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Bosch, Philipp, et al.
Publicado: (2021)

EMerging EULAR NETwork (EMEUNET): a remarkable foundation for the future
por: Alunno, Alessia, et al.
Publicado: (2021)

Analysing cord blood levels of TNF inhibitors to validate the EULAR points to consider for TNF inhibitor use during pregnancy
por: Ghalandari, Nafise, et al.
Publicado: (2022)

Enthesitis: Much More Than Focal Insertion Point Inflammation
por: Watad, Abdulla, et al.
Publicado: (2018)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

Mentoring for postdoctoral researchers in rheumatology: the Emerging EULAR Network (EMEUNET) post-doc mentoring programme
por: Rodríguez-Carrio, Javier, et al.
Publicado: (2020)

Effectiveness of remote care interventions: a systematic review informing the 2022 EULAR Points to Consider for remote care in rheumatic and musculoskeletal diseases
por: Marques, Andréa, et al.
Publicado: (2022)

Correction: Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
Publicado: (2022)

Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
por: Burska, Agata, et al.
Publicado: (2023)

2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis
por: Braun, J, et al.
Publicado: (2011)

Analysing and reporting of observational data: a systematic review informing the EULAR points to consider when analysing and reporting comparative effectiveness research with observational data in rheumatology
por: Lauper, Kim, et al.
Publicado: (2021)

Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection
por: McGonagle, Dennis, et al.
Publicado: (2021)

Workforce requirements in rheumatology: a systematic literature review informing the development of a workforce prediction risk of bias tool and the EULAR points to consider
por: Unger, Julia, et al.
Publicado: (2018)

Prevention, screening, assessing and managing of non-adherent behaviour in people with rheumatic and musculoskeletal diseases: systematic reviews informing the 2020 EULAR points to consider
por: Ritschl, Valentin, et al.
Publicado: (2020)

Health-care workers recovered from natural SARS-CoV-2 infection should be exempt from mandatory vaccination edicts
por: McGonagle, Dennis G
Publicado: (2022)

Correspondence on "ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update"
por: Braun, Juergen
Publicado: (2023)

An Immunomodulatory Transcriptional Signature Associated With Persistent Listeria Infection in Hepatocytes
por: Descoeudres, Natalie, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_16as09iive05fgh2ep4s1ovq0i